Clinical Trial Update: Clinical Study of VG161 in Advanced Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical study of VG161 for advanced intrahepatic cholangiocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• VG161

Snippet

Sponsor: CNBG-Virogin Biotech (Shanghai) Ltd. | Conditions: Advanced Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING